Curevac N.V. (CVAC)
$6.41
0.42 (6.15%)
CVAC Stock Quote Delayed 30 Minutes
Why Science and Economics Might Justify CureVac
Amid a sea of red ink in the Covid-19 vaccine space, CureVac stock has gone against the grain, printing some sizable gains. Can investors trust the momentum for CureVac?
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
1.86M
Day's Range
$6.35 - $6.93
52-Week Range
$5.47 - $12.79
Dividend & Yield
N/A (N/A)
CVAC Stock Predictions, Articles, and Curevac N.V. News
CureVac Stock Has Been Hot Following Its Recent IPO
CureVac has extensive collaborations globally as well as a range of drug candidates. CureVac stock is a high-risk, high-return investment.
CureVac Stock Soars After Talks of Supplying Vaccines for the EU
CureVac stock soars after the company announced that it was in talks of supplying the vaccine to EU member states.
CureVac Is a Bet on a Safe and Effective Vaccine
CureVac is a bet on a winning Covid-19 vaccine that is effective and safe. Buying CureVac stock could produce a 27.5% annual compounded return over the next two years.
CureVac IPO: 13 Things for Potential CVAC Stock Investors to Know
The CureVac (CVAC) IPO is underway Friday and potential investors will want to keep an eye on the stock as it's seeing massive gains.
